Skip to main content
Signal8

Hemostemix Inc. (HMTXF)

Sector: Biotechnology

Industry: Biotechnology

Hemostemix Inc. logo

Hemostemix Inc.

OTC:HMTXFHealthcare
-31.71%$0.0239
CLOSED
Mkt Cap$5.05M
EV-
Float168.41M
O/S211.44M
VOL79K sh
$ Vol$2K
RVOL1.85×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Hemostemix Inc. logoOTC:HMTXFClosed$0.0239-31.71%
Historical Data
DateOpenHighLowCloseVolume
Nov 16, 20260.03060.03060.02390.023979,000
Nov 9, 20260.03500.03500.03500.035041,000
Nov 6, 20260.03500.03610.03500.0350121,100
Nov 5, 20260.03600.03600.03570.035712,000
Nov 3, 20260.03700.03700.03660.036632,999
Oct 23, 20260.04090.04090.04090.040911,000
Oct 21, 20260.04030.04030.04030.04032,000
Oct 16, 20260.04080.04080.04010.040124,463
Oct 13, 20260.04210.04210.04010.040110,500
Oct 2, 20260.04350.04350.04350.0435220
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Hemostemix, Inc. is a clinical-stage biotechnology company, which is focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases.

The firm's, ACP-01, lead clinical stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia.

The company was founded by Roger Bergersen and Thomas A. Smeenk in 2006 and is headquartered in Calgary, Canada.

Key Metrics
Market Cap$5.05M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 211.44M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryCACA
IPO Date-
Shares Outstanding211.44M
Authorized Shares
Float168.41M
52-Week Range
$0.0239$0.0762
$0.0239(0th percentile)
Volume
Average Daily Volume42.73K
79.00K today vs 42.73K avg(+85%)

30d Avg

42.73K

60d Avg

30.49K

90d Avg

26.89K

Earnings
Dividend History
No dividend history available

Hemostemix Inc. (OTC: HMTXF) traded at $0.0239 on Nov 16, 2026, down 31.71% from the previous close of $0.0350. 52-week range: $0.0239 to $0.0762. The company is in the Healthcare sector (Biotechnology).